Models are substitutable. Workflows aren't. Why the orchestration and MCP layer is the right place for clinical trials to invest now.
The operational complexity goes up at every step. The pattern in the results does not.
The gap in clinical trial AI isn't the model. It's the infrastructure to govern it.
International biopharma sponsor and partner CRO maximize flexibility of Judi in DSMB for Phase 2 multinational clinical program
Meet AG Mednet's Mike Noonan, Senior Project Manager, Trial Delivery
United States-based biopharma leverages scalability of Judi in Imaging on three concurrent pulmonary oncology trials
Meet AG Mednet's Angela Jeffries, Program Manager / Team Lead, Trial Delivery
United States-based medical device sponsor and partner CRO leverage flexibility of Judi in DSMB for novel cardiovascular implant trial
Recognizing distinguished leaders within the clinical development community
Meet AG Mednet's Nancy O'Hearn, Client Engagement Manager
European-based biopharma and partner CRO employ dynamic controls of Judi in Adjudication and Site & User Qualification
Meet AG Mednet's Mark Gee, Director of Client Engagement
European-based pharmaceutical company and major CRO utilize dexterity of Judi in Eligibility
